Quick answers
- What is Adenosine used for?
- The FDA-approved label (Adenosine, Remedyrepack Inc., August 31, 2026) says: “Intravenous adenosine injection is indicated for the following. Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine injection administration. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Adenosine have a boxed warning?
- No. None of the 24 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Adenosine?
- No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
- Has Adenosine been recalled?
- No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
- Who makes Adenosine?
- 13 companies list prescription products of Adenosine in the FDA NDC Directory, including Mylan Institutional LLC, HF Acquisition Co LLC, DBA HealthFirst and Fresenius Kabi USA, LLC.
What Adenosine is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Intravenous adenosine injection is indicated for the following. Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver), should be attempted prior to adenosine injection administration. …
— FDA label: Adenosine, Remedyrepack Inc., effective August 31, 2026. Read the full label on DailyMed →
The FDA has 24 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 24 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Injection, solution · Injection · Solution |
|---|---|
| Route | Intravenous |
| Prescription products | 29 in the FDA NDC Directory |
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Mylan Institutional LLC5 products
- HF Acquisition Co LLC, DBA HealthFirst5 products
- Fresenius Kabi USA, LLC3 products
- Gland Pharma Limited3 products
- Medical Purchasing Solutions, LLC2 products
- Meitheal Pharmaceuticals Inc.2 products
- Sagent Pharmaceuticals2 products
- Eugia US LLC2 products
- NorthStar Rx LLC2 products
- ProPharma Distribution2 products
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.1 product
- Remedyrepack Inc.1 product
- Henry Schein, Inc.1 product
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (10)
- ANDA077133Fresenius Kabi USA · April 27, 2005
- ANDA077283Gland Pharma Ltd · June 14, 2007
- ANDA078686Mylan Labs Ltd · May 13, 2009
- ANDA077425Meitheal · August 29, 2013
- ANDA090212Mylan Asi · March 28, 2014
- ANDA202313Avet Lifesciences · September 15, 2014
- ANDA205331Eugia Pharma · November 2, 2017
- ANDA077897Fresenius Kabi USA · November 27, 2017
- ANDA206778Gland · February 16, 2018
- ANDA205568Fresenius Kabi USA · April 16, 2018
Shortage status
The FDA drug shortage list does not show these products.
Recalls
No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.
Official identifiers
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Adenosine, Remedyrepack Inc., effective August 31, 2026; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →